Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Treasury Shares (2021 - 2026)

NeuroPace has reported Treasury Shares over the past 6 years, most recently at $1.2 million for Q1 2026.

  • For Q1 2026, Treasury Shares fell 76.89% year-over-year to $1.2 million; the TTM value through Mar 2026 reached $1.2 million, down 76.89%, while the annual FY2025 figure was $1.2 million, 20.43% down from the prior year.
  • Treasury Shares for Q1 2026 was $1.2 million at NeuroPace, up from $1.2 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $5.3 million in Q1 2025 and troughed at $1282.0 in Q2 2024.
  • A 5-year average of $1.7 million and a median of $1.6 million in 2024 define the central range for Treasury Shares.
  • On a YoY basis, Treasury Shares climbed as much as 168009.78% in 2024 and fell as far as 99.96% in 2024.
  • Year by year, Treasury Shares stood at $1.8 million in 2022, then soared by 38.41% to $2.4 million in 2023, then plummeted by 39.1% to $1.5 million in 2024, then fell by 20.43% to $1.2 million in 2025, then increased by 3.42% to $1.2 million in 2026.
  • Business Quant data shows Treasury Shares for NPCE at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.